Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phagosomal membrane of antigen-presenting cells (APCs), such as macrophages and dendritic cells, is a dynamic lipid bilayer that forms around ingested particles during phagocytosis [Savina & Amigorena, 2007, Immunol Rev]. It serves as a critical platform for the innate and adaptive immune responses, facilitating the degradation of pathogens and the subsequent processing of antigens for presentation on MHC molecules [Guermonprez et al., 2002, Nature]. The membrane contains various proteins, including proton pumps (V-ATPases) for acidification, NADPH oxidase for reactive oxygen species production, and Toll-like receptors (TLRs) for pathogen recognition [Flannagan et al., 2009, Nat Rev Microbiol]. While not a single molecular target, the phagosomal membrane and its associated processes are focal points for therapeutic intervention in infectious diseases, where pathogens like Mycobacterium tuberculosis evade destruction by manipulating membrane fusion [Russell, 2001, Nat Rev Mol Cell Biol]. Additionally, modulating phagosomal functions, such as pH or maturation rate, is a strategy in cancer immunotherapy to enhance the cross-presentation of tumor antigens to CD8+ T cells [Joffre et al., 2012, Nat Rev Immunol]. Drugs like chloroquine interact with this compartment by neutralizing its acidic environment, thereby affecting antigen processing and viral entry [Savarino et al., 2003, Lancet Infect Dis].
Modulation of phagosomal pH and inhibition of phagosome-lysosome fusion
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phagosomal membrane of antigen-presenting cells.